SARcopenia Assessment in Hypertension: The SARAH Study.

Murat Kara1, Özgür Kara, Yasin Ceran

  • 1From the Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey (MK, BK, EGK, PA, HO, LÖ); Department of Internal Medicine, Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey (ÖK, TCK, BNÇ, MED, ED, GT); Department of Business and Technology Management, Korea Advanced Institute of Science and Technology, Seoul, South Korea (YC); Combined Military Hospital & Quetta Institute of Medical Sciences, Quetta, Pakistan (SR); Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Ankara, Turkey (YD); Physical Medicine and Rehabilitation Hospital, Andalous, Kuwait (DS, AJA); Department of Physical Medicine and Rehabilitation, Physical Medicine and Rehabilitation Hospital, Andalous, Kuwait (SAA); Department of Physical Medicine and Rehabilitation, Ankara City Hospital, Ankara, Turkey (AMA, FÜM); Department of Physical Medicine and Rehabilitation, University of Health Science, Basaksehir Cam and Sakura City Hospital, İstanbul, Turkey (EC); Department of Physical and Rehabilitation Medicine, Dokuz Eylül University Medical School, İzmir, Turkey (B. Dilek); Department of Physical and Rehabilitation Medicine, Kozan State Hospital, Adana, Turkey (MAC); Department of Physical Medicine and Rehabilitation, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey (PY); Charles University and General University Hospital, Prague, Czech Republic (KM); Department of Physical Medicine and Rehabilitation, University of Health Sciences, Sisli Hamidiye Etfal Teaching and Research Hospital, Istanbul, Turkey (B. Doğu); Department of Physical and Rehabilitation Medicine, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey (GK); Department of Physical Medicine and Rehabilitation, Celal Bayar University, Manisa, Turkey (ZÜ); Department of Physical Medicine and Rehabilitation, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal (JB, SP); Department of Physical Medicine and Rehabilitation, İstanbul University-Cerrahpaşa Cerrahpaşa School of Medicine, İstanbul, Turkey (DP); Department of Physical Medicine and Rehabilitation, Mersin University Faculty of Medicine, Mersin, Turkey (OG); Department of Neurology, Stanford University, Stanford, California (MB); and Division of Epidemiology, Department of Public Health, Hacettepe University Medical School, Ankara, Turkey (BÇ).

Summary

Hypertension significantly increases sarcopenia risk. Angiotensin-converting enzyme inhibitors improved muscle function, while angiotensin II receptor blockers enhanced muscle mass and physical performance in females, indicating differential effects of these medications.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
64
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
108
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
102
Assessing Blood pressure in the Leg01:11

Assessing Blood pressure in the Leg

Proper measurement of leg blood pressure is a critical skill for healthcare providers, ensuring precise and reliable readings. When performed correctly, this procedure informs patient care and enhances the efficacy of interventions. The following text outlines step-by-step guidelines to measure blood pressure in the leg, providing clarity and ease of understanding for practitioners.
Preparation:
4.8K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
55